Float Short %

18.45

Margin Of Safety %

Put/Call OI Ratio

0.2

EPS Next Q Diff

-1.85

EPS Last/This Y

1.11

EPS This/Next Y

0.36

Price

7.23

Target Price

20.07

Analyst Recom

Performance Q

9.88

Relative Volume

0.94

Beta

1.65

Ticker: ABEO

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-07-28	ABEO	6.62	0.19	0.92	37382
2025-07-29	ABEO	6.76	0.20	0.06	37696
2025-07-30	ABEO	6.8	0.20	0.14	37809
2025-07-31	ABEO	6.37	0.20	0.01	37816
2025-08-01	ABEO	6.49	0.19	2.44	37903
2025-08-04	ABEO	6.42	0.20	0.16	38196
2025-08-05	ABEO	6.47	0.20	0.00	38211
2025-08-06	ABEO	6.39	0.20	0.00	38679
2025-08-07	ABEO	6.26	0.20	0.18	38737
2025-08-08	ABEO	6.26	0.20	0.33	38771
2025-08-11	ABEO	6.3	0.20	0.08	38788
2025-08-12	ABEO	6.39	0.20	0.17	39261
2025-08-13	ABEO	6.56	0.20	0.33	39223
2025-08-14	ABEO	7.24	0.20	0.30	39208
2025-08-15	ABEO	7.12	0.19	0.03	39139
2025-08-18	ABEO	6.92	0.20	0.06	38110
2025-08-19	ABEO	6.84	0.20	0.20	38189
2025-08-20	ABEO	7	0.20	0.23	38289
2025-08-21	ABEO	7.12	0.20	0.24	38300
2025-08-22	ABEO	7.23	0.20	0.00	38406
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-07-28	ABEO	6.59	10.4	-	-0.46
2025-07-29	ABEO	6.75	10.4	-	-0.46
2025-07-30	ABEO	6.80	10.4	-	-0.46
2025-07-31	ABEO	6.37	10.4	-	-0.46
2025-08-01	ABEO	6.49	10.4	-	-0.46
2025-08-04	ABEO	6.42	10.4	-	-0.46
2025-08-05	ABEO	6.47	10.4	-	-0.46
2025-08-06	ABEO	6.39	10.4	-	-0.46
2025-08-07	ABEO	6.27	10.4	-	-0.46
2025-08-08	ABEO	6.26	10.4	-	-0.46
2025-08-11	ABEO	6.29	10.4	-	-0.46
2025-08-12	ABEO	6.40	10.4	-	-0.46
2025-08-13	ABEO	6.56	10.4	-	-0.46
2025-08-14	ABEO	7.23	10.4	-	-0.46
2025-08-15	ABEO	7.12	10.4	-	-0.46
2025-08-18	ABEO	6.91	10.4	-	-0.29
2025-08-19	ABEO	6.84	204.3	-	-0.29
2025-08-20	ABEO	7.00	204.3	-	-0.29
2025-08-21	ABEO	7.12	204.3	-	-0.29
2025-08-22	ABEO	7.23	-8.2	-	-0.44
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-07-28	ABEO	-4.60	9.27	18.65
2025-07-29	ABEO	-4.60	9.27	18.65
2025-07-30	ABEO	-4.60	9.27	18.65
2025-07-31	ABEO	-4.60	9.27	18.65
2025-08-01	ABEO	-4.54	9.27	18.65
2025-08-04	ABEO	-4.54	7.83	18.65
2025-08-05	ABEO	-4.54	7.83	18.65
2025-08-06	ABEO	-4.54	7.83	18.65
2025-08-07	ABEO	-4.54	7.83	18.65
2025-08-08	ABEO	-4.54	7.83	18.65
2025-08-11	ABEO	-4.54	7.84	18.65
2025-08-12	ABEO	-4.54	7.84	18.51
2025-08-13	ABEO	-4.54	7.84	18.51
2025-08-14	ABEO	-4.54	7.84	18.51
2025-08-15	ABEO	-4.54	7.84	18.51
2025-08-18	ABEO	-4.84	19.69	18.47
2025-08-19	ABEO	-4.84	19.69	18.47
2025-08-20	ABEO	-4.84	19.69	18.47
2025-08-21	ABEO	-4.84	19.69	18.45
2025-08-22	ABEO	-4.86	19.69	18.45
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

1.71

Avg. EPS Est. Current Quarter

-0.34

Avg. EPS Est. Next Quarter

-0.14

Insider Transactions

-4.86

Institutional Transactions

19.69

Beta

1.65

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

100

Growth Score

Sentiment Score

Actual DrawDown %

92.4

Max Drawdown 5-Year %

-97.3

Target Price

20.07

P/E

11.46

Forward P/E

42.95

PEG

P/S

926.86

P/B

2.27

P/Free Cash Flow

EPS

0.63

Average EPS Est. Cur. Y

-0.44

EPS Next Y. (Est.)

-0.08

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

14310.5

Relative Volume

0.94

Return on Equity vs Sector %

10.3

Return on Equity vs Industry %

23.2

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

Abeona Therapeutics Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 136

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is pz-cel, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.

stock quote shares ABEO – Abeona Therapeutics Inc Stock Price stock today

news today ABEO – Abeona Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch ABEO – Abeona Therapeutics Inc yahoo finance google finance

stock history ABEO – Abeona Therapeutics Inc invest stock market

stock prices ABEO premarket after hours

ticker ABEO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ABEO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y